Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 2.865 CHF -6.68%
Market Cap: 115.7m CHF

Wall Street
Price Targets

MOLN Price Targets Summary
Molecular Partners AG

Wall Street analysts forecast MOLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOLN is 10.71 CHF with a low forecast of 6.06 CHF and a high forecast of 15.75 CHF.

Lowest
Price Target
6.06 CHF
112% Upside
Average
Price Target
10.71 CHF
274% Upside
Highest
Price Target
15.75 CHF
450% Upside
Molecular Partners AG Competitors:
Price Targets
BRNS
Barinthus Biotherapeutics PLC
378% Upside
2696
Shanghai Henlius Biotech Inc
26% Downside
UTHR
United Therapeutics Corp
44% Upside
TNG
Transgene SA
78% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
1% Upside
LXRX
Lexicon Pharmaceuticals Inc
275% Upside
9688
Zai Lab Ltd
12% Upside
ABBV
Abbvie Inc
13% Upside

Revenue
Forecast

Revenue Estimate
Molecular Partners AG

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -17%. The projected CAGR for the next 3 years is 91%.

-17%
Past Growth
91%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOLN's stock price target?
Price Target
10.71 CHF

According to Wall Street analysts, the average 1-year price target for MOLN is 10.71 CHF with a low forecast of 6.06 CHF and a high forecast of 15.75 CHF.

What is Molecular Partners AG's Revenue forecast?
Projected CAGR
91%

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -17%. The projected CAGR for the next 3 years is 91%.

Back to Top